296 related articles for article (PubMed ID: 20160097)
1. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.
Nguyen QT; Olson ES; Aguilera TA; Jiang T; Scadeng M; Ellies LG; Tsien RY
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4317-22. PubMed ID: 20160097
[TBL] [Abstract][Full Text] [Related]
2. Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases.
Olson ES; Jiang T; Aguilera TA; Nguyen QT; Ellies LG; Scadeng M; Tsien RY
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4311-6. PubMed ID: 20160077
[TBL] [Abstract][Full Text] [Related]
3. Tumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide Dendrimer (ACPPD-Gd), a T1 Magnetic Resonance (MR) Molecular Imaging Agent.
Malone CD; Olson ES; Mattrey RF; Jiang T; Tsien RY; Nguyen QT
PLoS One; 2015; 10(9):e0137104. PubMed ID: 26336058
[TBL] [Abstract][Full Text] [Related]
4. Systemic in vivo distribution of activatable cell penetrating peptides is superior to that of cell penetrating peptides.
Aguilera TA; Olson ES; Timmers MM; Jiang T; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):371-81. PubMed ID: 20023744
[TBL] [Abstract][Full Text] [Related]
5. Targeting and imaging colorectal cancer by activatable cell-penetrating peptides.
Zeng Z; Chen J; Luo S; Dong J; Hu H; Yang Z; Feng X; Liu Y; Liu B; Pan G; Zhou FH; Wang L; Kang L
Am J Transl Res; 2020; 12(5):1754-1766. PubMed ID: 32509174
[TBL] [Abstract][Full Text] [Related]
6. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer.
Olson ES; Aguilera TA; Jiang T; Ellies LG; Nguyen QT; Wong EH; Gross LA; Tsien RY
Integr Biol (Camb); 2009 Jun; 1(5-6):382-93. PubMed ID: 20023745
[TBL] [Abstract][Full Text] [Related]
7. Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
Jiang T; Olson ES; Nguyen QT; Roy M; Jennings PA; Tsien RY
Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17867-72. PubMed ID: 15601762
[TBL] [Abstract][Full Text] [Related]
8. Tumor targeting of MMP-2/9 activatable cell-penetrating imaging probes is caused by tumor-independent activation.
van Duijnhoven SM; Robillard MS; Nicolay K; Grüll H
J Nucl Med; 2011 Feb; 52(2):279-86. PubMed ID: 21233187
[TBL] [Abstract][Full Text] [Related]
9. Gelatinase activity imaged by activatable cell-penetrating peptides in cell-based and in vivo models of stroke.
Chen S; Cui J; Jiang T; Olson ES; Cai QY; Yang M; Wu W; Guthrie JM; Robertson JD; Lipton SA; Ma L; Tsien RY; Gu Z
J Cereb Blood Flow Metab; 2017 Jan; 37(1):188-200. PubMed ID: 26681768
[TBL] [Abstract][Full Text] [Related]
10. Surgical molecular navigation with ratiometric activatable cell penetrating peptide for intraoperative identification and resection of small salivary gland cancers.
Hussain T; Savariar EN; Diaz-Perez JA; Messer K; Pu M; Tsien RY; Nguyen QT
Head Neck; 2016 May; 38(5):715-23. PubMed ID: 25521629
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model.
Orosco RK; Savariar EN; Weissbrod PA; Diaz-Perez JA; Bouvet M; Tsien RY; Nguyen QT
J Surg Oncol; 2016 Feb; 113(2):138-43. PubMed ID: 26799257
[TBL] [Abstract][Full Text] [Related]
12. Fluorescent Image-Guided Surgery with an Anti-Prostate Stem Cell Antigen (PSCA) Diabody Enables Targeted Resection of Mouse Prostate Cancer Xenografts in Real Time.
Sonn GA; Behesnilian AS; Jiang ZK; Zettlitz KA; Lepin EJ; Bentolila LA; Knowles SM; Lawrence D; Wu AM; Reiter RE
Clin Cancer Res; 2016 Mar; 22(6):1403-12. PubMed ID: 26490315
[TBL] [Abstract][Full Text] [Related]
13. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy.
Li X; Schumann C; Albarqi HA; Lee CJ; Alani AWG; Bracha S; Milovancev M; Taratula O; Taratula O
Theranostics; 2018; 8(3):767-784. PubMed ID: 29344305
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma-targeting triangular gadolinium oxide nanoplates for precise excision of cancer.
Jin Y; Li Y; Yang X; Tian J
Acta Biomater; 2019 Mar; 87():223-234. PubMed ID: 30669004
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Activatable Clinical Nanoprobe for Cancer Imaging.
Reichel D; Tripathi M; Butte P; Saouaf R; Perez JM
Nanotheranostics; 2019; 3(2):196-211. PubMed ID: 31183314
[No Abstract] [Full Text] [Related]
16. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
Kurbegovic S; Juhl K; Sørensen KK; Leth J; Willemoe GL; Christensen A; Adams Y; Jensen AR; von Buchwald C; Skjøth-Rasmussen J; Ploug M; Jensen KJ; Kjaer A
Theranostics; 2021; 11(15):7159-7174. PubMed ID: 34158842
[TBL] [Abstract][Full Text] [Related]
17. Activatable Cell-Penetrating Peptide Conjugated Polymeric Nanoparticles with Gd-Chelation and Aggregation-Induced Emission for Bimodal MR and Fluorescence Imaging of Tumors.
Xia B; Yan X; Fang WW; Chen S; Jiang Z; Wang J; Sun TC; Li Q; Li Z; Lu Y; He T; Cao B; Yang CT
ACS Appl Bio Mater; 2020 Mar; 3(3):1394-1405. PubMed ID: 35021632
[TBL] [Abstract][Full Text] [Related]
18. In vivo internal tumor illumination by telomerase-dependent adenoviral GFP for precise surgical navigation.
Kishimoto H; Zhao M; Hayashi K; Urata Y; Tanaka N; Fujiwara T; Penman S; Hoffman RM
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14514-7. PubMed ID: 19706537
[TBL] [Abstract][Full Text] [Related]
19. Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides.
Whitney M; Crisp JL; Olson ES; Aguilera TA; Gross LA; Ellies LG; Tsien RY
J Biol Chem; 2010 Jul; 285(29):22532-41. PubMed ID: 20460372
[TBL] [Abstract][Full Text] [Related]
20. Identification of High-Risk Plaques by MRI and Fluorescence Imaging in a Rabbit Model of Atherothrombosis.
Hua N; Baik F; Pham T; Phinikaridou A; Giordano N; Friedman B; Whitney M; Nguyen QT; Tsien RY; Hamilton JA
PLoS One; 2015; 10(10):e0139833. PubMed ID: 26448434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
